| View |
|
DRP-11857
|
Iron
|
None
|
104.54mg (equivalent to 325mg Ferrous Sulfate)
|
Film-coated Tablet
|
Anti-anemic
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial (OTC)
|
11 May 2022
|
11 May 2027
|
| View |
|
HRP-519
|
Chlorhexidine Digluconate
|
Rapichlor
|
2mg/mL (0.2% w/v)
|
Topical Solution
|
Antiseptic
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (HR)
|
11 May 2022
|
11 May 2027
|
| View |
|
DRP-11848
|
Sitagliptin (as phosphate monohydrate) + Metformin
Hydrochloride
|
Volrea-M
|
50mg/500mg
|
Film-Coated Tablets
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
08 July 2022
|
10 May 2027
|
| View |
|
DRP-11847
|
Sitagliptin (as phosphate monohydrate) + Metformin
Hydrochloride
|
Volrea-M
|
50mg/ 1g
|
Film-Coated Tablets
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
10 May 2022
|
10 May 2027
|
| View |
|
DRP-11858
|
Sterile Water for Injection
|
None
|
-
|
Solution for Injection
|
Diuent
|
Aishwarya Healthcare
|
India
|
Initial
|
11 May 2022
|
11 May 2027
|
| View |
|
DR-XY48006
|
Fentanyl (as Citrate)
|
Sublimaze
|
50 mcg/mL
|
Solution for Injection (I.V.)
|
Opioid Analgesic
|
DEMO S.A Pharmaceutical Industry
|
Greece
|
Initial (Correction
|
17 November 2023
|
10 May 2027
|
| View |
|
DRP-11808
|
5% Dextrose in Water
|
Saph-D5W
|
5 g/ 100 mL (5%w/v)
|
Solution for IV Infusion
|
Parenteral Rehydration Solution
|
Althea Pharma Pvt Ltd
|
India
|
Initial
|
06 May 2022
|
06 May 2027
|
| View |
|
DRP-11860
|
Isoniazid + Pyridoxine HCI
|
Isosaph-110
|
100mg/10mg per 5mL
|
Syrup
|
Anti-Tuberculosis
|
Azine Healthcare Pvt. Ltd.
|
India
|
Initial
|
11 May 2022
|
11 May 2027
|
| View |
|
DRP-11861
|
Isoniazid + Pyridoxine HCI
|
Isosaph-212
|
200mg/12mg per 5mL
|
Syrup
|
-
|
Azine Healthcare Pvt. Ltd.
|
India
|
Initial
|
11 May 2022
|
11 May 2027
|
| View |
|
HRP-520
|
Povidone Iodine
|
Oradine
|
4.5 mg/mL (0.45% w/v)
|
Throat Spray Solution
|
-
|
Kohl Industries Corporation
|
Philippines
|
Initial (HR) (Correction)
|
06 May 2022
|
19 April 2027
|
| View |
|
DR-XY48005
|
Teneligliptin (as hydrobromide hydrate)
|
Tenepride-20
|
20 mg
|
Film Coated tablet
|
Antidiabetic Agent (Dipeptidyl peptidase 4 (DPP-4) inhibitors)
|
Micro Labs Limited
|
India
|
Monitored Release (MR)
|
06 May 2022
|
06 May 2027
|
| View |
|
DR-XY48004
|
Milrinone
|
Myomil
|
1mg/mL
|
Concentrate Solution for Infusion (IV)
|
-
|
Claris Injectables Limited
|
India
|
Monitored Release
|
06 May 2022
|
06 May 2027
|
| View |
|
DRP-11840
|
Dutasteride + Tamsulosin Hydrochloride
|
Prostmax-D
|
0.5 mg/0.4 mg
|
Capsule
|
Drugs used in Benign Prostatic Hypertrophy
|
Titan Laboratories Pvt. Ltd.
|
India
|
Initial
|
06 May 2022
|
06 May 2027
|
| View |
|
DR-XY48012
|
Fexofenadine Hydrochloride
|
Zimafen
|
120 mg
|
Film-Coated Tablet
|
-
|
Zim Laboratories Limited
|
India
|
Initial
|
12 May 2022
|
12 May 2027
|
| View |
|
DRP-11843
|
Emtricitabine + Tenofovir disoproxil fumarate
|
None
|
200 mg/300 mg
|
Film-Coated Tablet
|
Antiviral Combination
|
Laurus Labs Limited (Unit II)
|
India
|
Monitored Release
|
10 May 2022
|
10 May 2025
|
| View |
|
DR-XY48013
|
Irinotecan hydrochloride
|
Irican
|
20 mg/mL
|
Solution for IV Infusion
|
Antineoplastic
|
Jiangsu Hengrui Medicine Co., Ltd.
|
China
|
Initial
|
12 May 2022
|
12 May 2027
|
| View |
|
DRP-11842
|
Emtricitabine + Tenofovir disoproxil fumarate
|
Emteno
|
200 mg/ 300 mg
|
Film-Coated Tablet
|
-
|
Laurus Labs Limited (Unit II)
|
India
|
Monitored Release
|
10 May 2022
|
10 May 2025
|
| View |
|
DRP-11851
|
Montelukast (as sodium) + Levocetirizine Hydrochloride
|
Cetrikast
|
10 mg/5 mg
|
Film Coated Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Cooper Pharma Limited
|
India
|
Initial
|
10 May 2022
|
10 May 2027
|
| View |
|
DR-XY48008
|
Donepezil Hydrochloride
|
Alzime
|
10 mg
|
Film-Coated Tablet
|
Anticholinesterase
|
Berlin Pharmaceutical Industry Co. Ltd.
|
Thailand
|
Initial
|
10 May 2022
|
10 May 2027
|
| View |
|
DRP-11837
|
Losartan Potassium + Amlodipine (As Besilate)
|
None
|
50 mg/ 5 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blockers (ARBs) and Calcium
Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial (from Monitored Release)
|
06 May 2022
|
10 February 2025
|